Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution At AGBT
Portfolio Pulse from Benzinga Newsdesk
Twist Bioscience Corporation (NASDAQ:TWST) announced the early access of its Twist Flex Prep Ultra High-Throughput (UHT) Kit, designed to significantly reduce costs and increase efficiency in NGS workflows, particularly in agricultural genomics. The kit features novel Normalization By Ligation (NBL) technology for self-normalizing sample inputs, enhanced multiplexing capabilities, and compatibility with automation systems. This innovation is expected to accelerate NGS adoption in AgBio by offering a scalable, streamlined, and cost-effective solution. Twist Bioscience will showcase this technology at the AGBT General Meeting in Orlando, FL.
February 05, 2024 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Twist Bioscience's introduction of the Twist Flex Prep UHT Kit represents a significant advancement in NGS workflow efficiency and cost reduction, particularly for agricultural genomics. This innovation could drive broader adoption of NGS technologies in AgBio, potentially leading to increased demand for Twist Bioscience's products.
The introduction of the Twist Flex Prep UHT Kit by Twist Bioscience directly impacts the company by potentially increasing its market share in the NGS space, especially within agricultural genomics. The kit's cost-effectiveness and efficiency could lead to higher demand for Twist's products, positively affecting its financial performance in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100